Showing results (411-420 of 607) with videos related to

Sort By:
Pageof 61
Circulation Research|February 26, 2011
Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathwaysGiulia Chinetti-Gbaguidi, Morgane Baron, Mohamed Amine Bouhlel, et al.
The Journal of Biological Chemistry|February 1, 2006
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in miceBertrand Cariou, Kirsten van Harmelen, Daniel Duran-Sandoval, et al.
Heart (British Cardiac Society)|June 13, 2022
Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosisAugustin Coisne, David Montaigne, Sandro Ninni, et al.
Circulation Research|February 26, 2003
Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolismAndries J Gilde, Karin A J M van der Lee, Peter H M Willemsen, et al.
Journal of the American College of Cardiology|May 7, 2013
Mitochondrial dysfunction as an arrhythmogenic substrate: a translational proof-of-concept study in patients with metabolic syndrome in whom post-operative atrial fibrillation developsDavid Montaigne, Xavier Marechal, Philippe Lefebvre, et al.
Diabetes|January 6, 2017
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse ModelMichael Joubert, Benoît Jagu, David Montaigne, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 9, 2014
Effects of the PPAR-α agonist fenofibrate on acute and short-term consequences of brain ischemiaThavarak Ouk, Sophie Gautier, Maud Pétrault, et al.
British Journal of Pharmacology|May 30, 2024
Insulin-degrading enzyme inhibition increases the unfolded protein response and favours lipid accumulation in the liverMarine Andres, Nathalie Hennuyer, Khamis Zibar, et al.
The Journal of Clinical Investigation|July 3, 2002
Increased ABCA1 activity protects against atherosclerosisRoshni R Singaraja, Catherine Fievet, Graciela Castro, et al.
Plos One|February 2, 2012
LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver diseaseVeerle Bieghs, Patrick J Van Gorp, Kristiaan Wouters, et al.
Pageof 61